Global Intravitreal (IVT) Injectables Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028


Jul, 2022 | Report ID: 236104 | 165 | Medical Devices

The Intravitreal (IVT) Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Intravitreal (IVT) Injectables market size is estimated to be worth US$ 14950 million in 2021 and is forecast to a readjusted size of USD 23480 million by 2028 with a CAGR of 6.7% during review period. Hospital Pharmacies accounting for % of the Intravitreal (IVT) Injectables global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-VEGF segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Intravitreal (IVT) Injectables include Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, Allergan, and Alimera Sciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Intravitreal (IVT) Injectables market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Anti-VEGF

Corticosteroids

Antibiotics

Antivirals

Antifungals

Market segment by Application can be divided into

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Mail Order Pharmacies

Others

The key market players for global Intravitreal (IVT) Injectables market are listed below:

Regeneron Pharmaceuticals

Bausch & Lomb

Novartis

Allergan

Alimera Sciences

ThromboGenics

Bristol-Myers Squibb

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Intravitreal (IVT) Injectables product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Intravitreal (IVT) Injectables, with price, sales, revenue and global market share of Intravitreal (IVT) Injectables from 2019 to 2022.

Chapter 3, the Intravitreal (IVT) Injectables competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Intravitreal (IVT) Injectables breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intravitreal (IVT) Injectables market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Intravitreal (IVT) Injectables.

Chapter 13, 14, and 15, to describe Intravitreal (IVT) Injectables sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Intravitreal (IVT) Injectables Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Intravitreal (IVT) Injectables Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Anti-VEGF

1.2.3 Corticosteroids

1.2.4 Antibiotics

1.2.5 Antivirals

1.2.6 Antifungals

1.3 Market Analysis by Application

1.3.1 Overview: Global Intravitreal (IVT) Injectables Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Drug Stores

1.3.5 Mail Order Pharmacies

1.3.6 Others

1.4 Global Intravitreal (IVT) Injectables Market Size & Forecast

1.4.1 Global Intravitreal (IVT) Injectables Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Intravitreal (IVT) Injectables Sales in Volume (2017-2028)

1.4.3 Global Intravitreal (IVT) Injectables Price (2017-2028)

1.5 Global Intravitreal (IVT) Injectables Production Capacity Analysis

1.5.1 Global Intravitreal (IVT) Injectables Total Production Capacity (2017-2028)

1.5.2 Global Intravitreal (IVT) Injectables Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Intravitreal (IVT) Injectables Market Drivers

1.6.2 Intravitreal (IVT) Injectables Market Restraints

1.6.3 Intravitreal (IVT) Injectables Trends Analysis

2 Manufacturers Profiles

2.1 Regeneron Pharmaceuticals

2.1.1 Regeneron Pharmaceuticals Details

2.1.2 Regeneron Pharmaceuticals Major Business

2.1.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product and Services

2.1.4 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Bausch & Lomb

2.2.1 Bausch & Lomb Details

2.2.2 Bausch & Lomb Major Business

2.2.3 Bausch & Lomb Intravitreal (IVT) Injectables Product and Services

2.2.4 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Intravitreal (IVT) Injectables Product and Services

2.3.4 Novartis Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Allergan

2.4.1 Allergan Details

2.4.2 Allergan Major Business

2.4.3 Allergan Intravitreal (IVT) Injectables Product and Services

2.4.4 Allergan Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Alimera Sciences

2.5.1 Alimera Sciences Details

2.5.2 Alimera Sciences Major Business

2.5.3 Alimera Sciences Intravitreal (IVT) Injectables Product and Services

2.5.4 Alimera Sciences Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 ThromboGenics

2.6.1 ThromboGenics Details

2.6.2 ThromboGenics Major Business

2.6.3 ThromboGenics Intravitreal (IVT) Injectables Product and Services

2.6.4 ThromboGenics Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Bristol-Myers Squibb

2.7.1 Bristol-Myers Squibb Details

2.7.2 Bristol-Myers Squibb Major Business

2.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Product and Services

2.7.4 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Intravitreal (IVT) Injectables Breakdown Data by Manufacturer

3.1 Global Intravitreal (IVT) Injectables Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Intravitreal (IVT) Injectables Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Intravitreal (IVT) Injectables

3.4 Market Concentration Rate

3.4.1 Top 3 Intravitreal (IVT) Injectables Manufacturer Market Share in 2021

3.4.2 Top 6 Intravitreal (IVT) Injectables Manufacturer Market Share in 2021

3.5 Global Intravitreal (IVT) Injectables Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Intravitreal (IVT) Injectables Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Intravitreal (IVT) Injectables Market Size by Region

4.1.1 Global Intravitreal (IVT) Injectables Sales in Volume by Region (2017-2028)

4.1.2 Global Intravitreal (IVT) Injectables Revenue by Region (2017-2028)

4.2 North America Intravitreal (IVT) Injectables Revenue (2017-2028)

4.3 Europe Intravitreal (IVT) Injectables Revenue (2017-2028)

4.4 Asia-Pacific Intravitreal (IVT) Injectables Revenue (2017-2028)

4.5 South America Intravitreal (IVT) Injectables Revenue (2017-2028)

4.6 Middle East and Africa Intravitreal (IVT) Injectables Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Intravitreal (IVT) Injectables Sales in Volume by Type (2017-2028)

5.2 Global Intravitreal (IVT) Injectables Revenue by Type (2017-2028)

5.3 Global Intravitreal (IVT) Injectables Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Intravitreal (IVT) Injectables Sales in Volume by Application (2017-2028)

6.2 Global Intravitreal (IVT) Injectables Revenue by Application (2017-2028)

6.3 Global Intravitreal (IVT) Injectables Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Intravitreal (IVT) Injectables Sales by Type (2017-2028)

7.2 North America Intravitreal (IVT) Injectables Sales by Application (2017-2028)

7.3 North America Intravitreal (IVT) Injectables Market Size by Country

7.3.1 North America Intravitreal (IVT) Injectables Sales in Volume by Country (2017-2028)

7.3.2 North America Intravitreal (IVT) Injectables Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Intravitreal (IVT) Injectables Sales by Type (2017-2028)

8.2 Europe Intravitreal (IVT) Injectables Sales by Application (2017-2028)

8.3 Europe Intravitreal (IVT) Injectables Market Size by Country

8.3.1 Europe Intravitreal (IVT) Injectables Sales in Volume by Country (2017-2028)

8.3.2 Europe Intravitreal (IVT) Injectables Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Intravitreal (IVT) Injectables Sales by Type (2017-2028)

9.2 Asia-Pacific Intravitreal (IVT) Injectables Sales by Application (2017-2028)

9.3 Asia-Pacific Intravitreal (IVT) Injectables Market Size by Region

9.3.1 Asia-Pacific Intravitreal (IVT) Injectables Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Intravitreal (IVT) Injectables Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Intravitreal (IVT) Injectables Sales by Type (2017-2028)

10.2 South America Intravitreal (IVT) Injectables Sales by Application (2017-2028)

10.3 South America Intravitreal (IVT) Injectables Market Size by Country

10.3.1 South America Intravitreal (IVT) Injectables Sales in Volume by Country (2017-2028)

10.3.2 South America Intravitreal (IVT) Injectables Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2017-2028)

11.2 Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2017-2028)

11.3 Middle East & Africa Intravitreal (IVT) Injectables Market Size by Country

11.3.1 Middle East & Africa Intravitreal (IVT) Injectables Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Intravitreal (IVT) Injectables Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Intravitreal (IVT) Injectables and Key Manufacturers

12.2 Manufacturing Costs Percentage of Intravitreal (IVT) Injectables

12.3 Intravitreal (IVT) Injectables Production Process

12.4 Intravitreal (IVT) Injectables Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Intravitreal (IVT) Injectables Typical Distributors

13.3 Intravitreal (IVT) Injectables Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Intravitreal (IVT) Injectables Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Intravitreal (IVT) Injectables Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 4. Regeneron Pharmaceuticals Major Business

Table 5. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product and Services

Table 6. Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Bausch & Lomb Basic Information, Manufacturing Base and Competitors

Table 8. Bausch & Lomb Major Business

Table 9. Bausch & Lomb Intravitreal (IVT) Injectables Product and Services

Table 10. Bausch & Lomb Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Novartis Basic Information, Manufacturing Base and Competitors

Table 12. Novartis Major Business

Table 13. Novartis Intravitreal (IVT) Injectables Product and Services

Table 14. Novartis Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Allergan Basic Information, Manufacturing Base and Competitors

Table 16. Allergan Major Business

Table 17. Allergan Intravitreal (IVT) Injectables Product and Services

Table 18. Allergan Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Alimera Sciences Basic Information, Manufacturing Base and Competitors

Table 20. Alimera Sciences Major Business

Table 21. Alimera Sciences Intravitreal (IVT) Injectables Product and Services

Table 22. Alimera Sciences Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. ThromboGenics Basic Information, Manufacturing Base and Competitors

Table 24. ThromboGenics Major Business

Table 25. ThromboGenics Intravitreal (IVT) Injectables Product and Services

Table 26. ThromboGenics Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table 28. Bristol-Myers Squibb Major Business

Table 29. Bristol-Myers Squibb Intravitreal (IVT) Injectables Product and Services

Table 30. Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Global Intravitreal (IVT) Injectables Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 32. Global Intravitreal (IVT) Injectables Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 33. Market Position of Manufacturers in Intravitreal (IVT) Injectables, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 34. Global Intravitreal (IVT) Injectables Production Capacity by Company, (K Units): 2020 VS 2021

Table 35. Head Office and Intravitreal (IVT) Injectables Production Site of Key Manufacturer

Table 36. Intravitreal (IVT) Injectables New Entrant and Capacity Expansion Plans

Table 37. Intravitreal (IVT) Injectables Mergers & Acquisitions in the Past Five Years

Table 38. Global Intravitreal (IVT) Injectables Sales by Region (2017-2022) & (K Units)

Table 39. Global Intravitreal (IVT) Injectables Sales by Region (2023-2028) & (K Units)

Table 40. Global Intravitreal (IVT) Injectables Revenue by Region (2017-2022) & (USD Million)

Table 41. Global Intravitreal (IVT) Injectables Revenue by Region (2023-2028) & (USD Million)

Table 42. Global Intravitreal (IVT) Injectables Sales by Type (2017-2022) & (K Units)

Table 43. Global Intravitreal (IVT) Injectables Sales by Type (2023-2028) & (K Units)

Table 44. Global Intravitreal (IVT) Injectables Revenue by Type (2017-2022) & (USD Million)

Table 45. Global Intravitreal (IVT) Injectables Revenue by Type (2023-2028) & (USD Million)

Table 46. Global Intravitreal (IVT) Injectables Price by Type (2017-2022) & (USD/Unit)

Table 47. Global Intravitreal (IVT) Injectables Price by Type (2023-2028) & (USD/Unit)

Table 48. Global Intravitreal (IVT) Injectables Sales by Application (2017-2022) & (K Units)

Table 49. Global Intravitreal (IVT) Injectables Sales by Application (2023-2028) & (K Units)

Table 50. Global Intravitreal (IVT) Injectables Revenue by Application (2017-2022) & (USD Million)

Table 51. Global Intravitreal (IVT) Injectables Revenue by Application (2023-2028) & (USD Million)

Table 52. Global Intravitreal (IVT) Injectables Price by Application (2017-2022) & (USD/Unit)

Table 53. Global Intravitreal (IVT) Injectables Price by Application (2023-2028) & (USD/Unit)

Table 54. North America Intravitreal (IVT) Injectables Sales by Country (2017-2022) & (K Units)

Table 55. North America Intravitreal (IVT) Injectables Sales by Country (2023-2028) & (K Units)

Table 56. North America Intravitreal (IVT) Injectables Revenue by Country (2017-2022) & (USD Million)

Table 57. North America Intravitreal (IVT) Injectables Revenue by Country (2023-2028) & (USD Million)

Table 58. North America Intravitreal (IVT) Injectables Sales by Type (2017-2022) & (K Units)

Table 59. North America Intravitreal (IVT) Injectables Sales by Type (2023-2028) & (K Units)

Table 60. North America Intravitreal (IVT) Injectables Sales by Application (2017-2022) & (K Units)

Table 61. North America Intravitreal (IVT) Injectables Sales by Application (2023-2028) & (K Units)

Table 62. Europe Intravitreal (IVT) Injectables Sales by Country (2017-2022) & (K Units)

Table 63. Europe Intravitreal (IVT) Injectables Sales by Country (2023-2028) & (K Units)

Table 64. Europe Intravitreal (IVT) Injectables Revenue by Country (2017-2022) & (USD Million)

Table 65. Europe Intravitreal (IVT) Injectables Revenue by Country (2023-2028) & (USD Million)

Table 66. Europe Intravitreal (IVT) Injectables Sales by Type (2017-2022) & (K Units)

Table 67. Europe Intravitreal (IVT) Injectables Sales by Type (2023-2028) & (K Units)

Table 68. Europe Intravitreal (IVT) Injectables Sales by Application (2017-2022) & (K Units)

Table 69. Europe Intravitreal (IVT) Injectables Sales by Application (2023-2028) & (K Units)

Table 70. Asia-Pacific Intravitreal (IVT) Injectables Sales by Region (2017-2022) & (K Units)

Table 71. Asia-Pacific Intravitreal (IVT) Injectables Sales by Region (2023-2028) & (K Units)

Table 72. Asia-Pacific Intravitreal (IVT) Injectables Revenue by Region (2017-2022) & (USD Million)

Table 73. Asia-Pacific Intravitreal (IVT) Injectables Revenue by Region (2023-2028) & (USD Million)

Table 74. Asia-Pacific Intravitreal (IVT) Injectables Sales by Type (2017-2022) & (K Units)

Table 75. Asia-Pacific Intravitreal (IVT) Injectables Sales by Type (2023-2028) & (K Units)

Table 76. Asia-Pacific Intravitreal (IVT) Injectables Sales by Application (2017-2022) & (K Units)

Table 77. Asia-Pacific Intravitreal (IVT) Injectables Sales by Application (2023-2028) & (K Units)

Table 78. South America Intravitreal (IVT) Injectables Sales by Country (2017-2022) & (K Units)

Table 79. South America Intravitreal (IVT) Injectables Sales by Country (2023-2028) & (K Units)

Table 80. South America Intravitreal (IVT) Injectables Revenue by Country (2017-2022) & (USD Million)

Table 81. South America Intravitreal (IVT) Injectables Revenue by Country (2023-2028) & (USD Million)

Table 82. South America Intravitreal (IVT) Injectables Sales by Type (2017-2022) & (K Units)

Table 83. South America Intravitreal (IVT) Injectables Sales by Type (2023-2028) & (K Units)

Table 84. South America Intravitreal (IVT) Injectables Sales by Application (2017-2022) & (K Units)

Table 85. South America Intravitreal (IVT) Injectables Sales by Application (2023-2028) & (K Units)

Table 86. Middle East & Africa Intravitreal (IVT) Injectables Sales by Region (2017-2022) & (K Units)

Table 87. Middle East & Africa Intravitreal (IVT) Injectables Sales by Region (2023-2028) & (K Units)

Table 88. Middle East & Africa Intravitreal (IVT) Injectables Revenue by Region (2017-2022) & (USD Million)

Table 89. Middle East & Africa Intravitreal (IVT) Injectables Revenue by Region (2023-2028) & (USD Million)

Table 90. Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2017-2022) & (K Units)

Table 91. Middle East & Africa Intravitreal (IVT) Injectables Sales by Type (2023-2028) & (K Units)

Table 92. Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2017-2022) & (K Units)

Table 93. Middle East & Africa Intravitreal (IVT) Injectables Sales by Application (2023-2028) & (K Units)

Table 94. Intravitreal (IVT) Injectables Raw Material

Table 95. Key Manufacturers of Intravitreal (IVT) Injectables Raw Materials

Table 96. Direct Channel Pros & Cons

Table 97. Indirect Channel Pros & Cons

Table 98. Intravitreal (IVT) Injectables Typical Distributors

Table 99. Intravitreal (IVT) Injectables Typical Customers

List of Figures

Figure 1. Intravitreal (IVT) Injectables Picture

Figure 2. Global Intravitreal (IVT) Injectables Revenue Market Share by Type in 2021

Figure 3. Anti-VEGF

Figure 4. Corticosteroids

Figure 5. Antibiotics

Figure 6. Antivirals

Figure 7. Antifungals

Figure 8. Global Intravitreal (IVT) Injectables Revenue Market Share by Application in 2021

Figure 9. Hospital Pharmacies

Figure 10. Retail Pharmacies

Figure 11. Drug Stores

Figure 12. Mail Order Pharmacies

Figure 13. Others

Figure 14. Global Intravitreal (IVT) Injectables Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 15. Global Intravitreal (IVT) Injectables Revenue and Forecast (2017-2028) & (USD Million)

Figure 16. Global Intravitreal (IVT) Injectables Sales (2017-2028) & (K Units)

Figure 17. Global Intravitreal (IVT) Injectables Price (2017-2028) & (USD/Unit)

Figure 18. Global Intravitreal (IVT) Injectables Production Capacity (2017-2028) & (K Units)

Figure 19. Global Intravitreal (IVT) Injectables Production Capacity by Geographic Region: 2022 VS 2028

Figure 20. Intravitreal (IVT) Injectables Market Drivers

Figure 21. Intravitreal (IVT) Injectables Market Restraints

Figure 22. Intravitreal (IVT) Injectables Market Trends

Figure 23. Global Intravitreal (IVT) Injectables Sales Market Share by Manufacturer in 2021

Figure 24. Global Intravitreal (IVT) Injectables Revenue Market Share by Manufacturer in 2021

Figure 25. Intravitreal (IVT) Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 26. Top 3 Intravitreal (IVT) Injectables Manufacturer (Revenue) Market Share in 2021

Figure 27. Top 6 Intravitreal (IVT) Injectables Manufacturer (Revenue) Market Share in 2021

Figure 28. Global Intravitreal (IVT) Injectables Sales Market Share by Region (2017-2028)

Figure 29. Global Intravitreal (IVT) Injectables Revenue Market Share by Region (2017-2028)

Figure 30. North America Intravitreal (IVT) Injectables Revenue (2017-2028) & (USD Million)

Figure 31. Europe Intravitreal (IVT) Injectables Revenue (2017-2028) & (USD Million)

Figure 32. Asia-Pacific Intravitreal (IVT) Injectables Revenue (2017-2028) & (USD Million)

Figure 33. South America Intravitreal (IVT) Injectables Revenue (2017-2028) & (USD Million)

Figure 34. Middle East & Africa Intravitreal (IVT) Injectables Revenue (2017-2028) & (USD Million)

Figure 35. Global Intravitreal (IVT) Injectables Sales Market Share by Type (2017-2028)

Figure 36. Global Intravitreal (IVT) Injectables Revenue Market Share by Type (2017-2028)

Figure 37. Global Intravitreal (IVT) Injectables Price by Type (2017-2028) & (USD/Unit)

Figure 38. Global Intravitreal (IVT) Injectables Sales Market Share by Application (2017-2028)

Figure 39. Global Intravitreal (IVT) Injectables Revenue Market Share by Application (2017-2028)

Figure 40. Global Intravitreal (IVT) Injectables Price by Application (2017-2028) & (USD/Unit)

Figure 41. North America Intravitreal (IVT) Injectables Sales Market Share by Type (2017-2028)

Figure 42. North America Intravitreal (IVT) Injectables Sales Market Share by Application (2017-2028)

Figure 43. North America Intravitreal (IVT) Injectables Sales Market Share by Country (2017-2028)

Figure 44. North America Intravitreal (IVT) Injectables Revenue Market Share by Country (2017-2028)

Figure 45. United States Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Intravitreal (IVT) Injectables Sales Market Share by Type (2017-2028)

Figure 49. Europe Intravitreal (IVT) Injectables Sales Market Share by Application (2017-2028)

Figure 50. Europe Intravitreal (IVT) Injectables Sales Market Share by Country (2017-2028)

Figure 51. Europe Intravitreal (IVT) Injectables Revenue Market Share by Country (2017-2028)

Figure 52. Germany Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Intravitreal (IVT) Injectables Sales Market Share by Region (2017-2028)

Figure 58. Asia-Pacific Intravitreal (IVT) Injectables Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Intravitreal (IVT) Injectables Sales Market Share by Region (2017-2028)

Figure 60. Asia-Pacific Intravitreal (IVT) Injectables Revenue Market Share by Region (2017-2028)

Figure 61. China Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Korea Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America Intravitreal (IVT) Injectables Sales Market Share by Type (2017-2028)

Figure 68. South America Intravitreal (IVT) Injectables Sales Market Share by Application (2017-2028)

Figure 69. South America Intravitreal (IVT) Injectables Sales Market Share by Country (2017-2028)

Figure 70. South America Intravitreal (IVT) Injectables Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Type (2017-2028)

Figure 74. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Application (2017-2028)

Figure 75. Middle East & Africa Intravitreal (IVT) Injectables Sales Market Share by Region (2017-2028)

Figure 76. Middle East & Africa Intravitreal (IVT) Injectables Revenue Market Share by Region (2017-2028)

Figure 77. Turkey Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Egypt Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. South Africa Intravitreal (IVT) Injectables Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Manufacturing Cost Structure Analysis of Intravitreal (IVT) Injectables in 2021

Figure 82. Manufacturing Process Analysis of Intravitreal (IVT) Injectables

Figure 83. Intravitreal (IVT) Injectables Industrial Chain

Figure 84. Sales Channel: Direct Channel vs Indirect Channel

Figure 85. Methodology

Figure 86. Research Process and Data Source

Sample Request is not available